Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Diffusion-Weighted MRI for Screening Contralateral Breast Cancers in Patients With Newly Diagnosed Breast Cancer

NCT05307757 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT05307757
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05307757 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Diffusion-Weighted MRI for Screening Contralateral Breast Cancers in Patients With Newly Diagnosed Breast Cancer
Lead sponsor
Seoul National University Hospital
Phase
Observational
Overall status
Unknown status
Start date
May 1, 2022
Completion date
January 31, 2026
Enrollment
1,098 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer